Read + Share
Amedeo Smart
Independent Medical Education
Chou CL, Hsu HP, Li WS, Lee SW, et al. Upregulated Claudin-18.2 Is a Poor Prognostic Indicator for Rectal Cancer Patients Undergoing Preoperative Concurrent Chemoradiotherapy. Oncology 2026;104:552-563.PMID: 40618735
Email
LinkedIn
Privacy Policy